Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 5/1997

01-09-1997 | ORIGINAL ARTICLE

Evaluation of the cost of home care for terminally ill cancer patients

Authors: Marco Maltoni, Claudio Travaglini, Matteo Santi, Oriana Nanni, Emanuela Scarpi, Simonetta Benvenuti, Livia Albertazzi, Laura Amaducci, Stefania Derni, Laura Fabbri, Angelo Masi, Luigi Montanari, Giuseppe Pasini, Antonio Polselli, Umberto Tonelli, Paola Turci, Dino Amadori

Published in: Supportive Care in Cancer | Issue 5/1997

Login to get access
Metadata
Title
Evaluation of the cost of home care for terminally ill cancer patients
Authors
Marco Maltoni
Claudio Travaglini
Matteo Santi
Oriana Nanni
Emanuela Scarpi
Simonetta Benvenuti
Livia Albertazzi
Laura Amaducci
Stefania Derni
Laura Fabbri
Angelo Masi
Luigi Montanari
Giuseppe Pasini
Antonio Polselli
Umberto Tonelli
Paola Turci
Dino Amadori
Publication date
01-09-1997
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 5/1997
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s005200050098

Other articles of this Issue 5/1997

Supportive Care in Cancer 5/1997 Go to the issue

REVIEW ARTICLE

Treatment of neutropenic infection: trends towards monotherapy?

REVIEW ARTICLE

Assessment of nutritional status in cancer patients: widely neglected?

REVIEW ARTICLE

Controversies in new antibiotic therapy for ambulatory patients

REVIEW ARTICLE

Immuno-nutrition: designer diets in cancer

ORIGINAL ARTICLE

Fatigue in patients with cancer: results with National Cancer Institute of Canada Clinical Trials Group studies employing the EORTC QLQ-C30

SPECIAL ARTICLE

The treatment of febrile neutropenia: from the Dark Ages to the present
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits